NAMPT and Parkinson disease: The ability of FK866 to rescue α-syn-mediated neurite pathology in our cell model, if replicated in in vivo models, would suggest that targeting the NAD+ biosynthetic pathway, and NAMPT in particular, may be a viable therapeutic target for preventing, and potentially reversing, α-syn-mediated degeneration of neuronal connections seen in PD.